ELI BILLETER: Open Payments
NPI 1063817948 · SAINT AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 25 payments from 9 companies in 2025. Trend: 2023 $399 · 2024 $819 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $128 |
| Novo Nordisk Inc | 6 | $110 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Amgen Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| UCB, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: MOUNJARO, Ozempic, OTEZLA, Cologuard Collection Kit, Bimzelx, AIRSUPRA, MAVYRET, HETLIOZ.
Industry payments across FL — which companies pay providers there.
